Supply of Lidocaine Hydrochloride Jelly (2%)

The contract calls for the supply and delivery of Lidocaine Hydrochloride Jelly at a 2% concentration, packaged in 11mL single-use prefilled syringes, with ten syringes per box. All products must meet military-specific packaging standards, including compliance with shelf-life requirements to ensure long-term usability in storage and field conditions. Electronic invoicing protocols must be followed to align with Department of Defense procurement systems. The product is intended for use in medical applications requiring topical anesthesia and must be manufactured and delivered in full compliance with federal military specifications. The solicitation is issued under the NAICS code 325412 for pharmaceutical preparation manufacturing and is structured as a subcontract within the Medical Supply Chain Pharm FSA framework. The response deadline is August 10, 2026, with the opportunity posted on August 2, 2026, and all deliveries must be made to designated military logistics centers as required by the Department of Defense.